ELVN Enliven Therapeutics, Inc. | 1672619
Available Fillings
Total Fillings:578
| Form Type | Form Count |
|---|---|
| 8-K | 43 |
| UPLOAD | 7 |
| CORRESP | 10 |
| 10-Q | 15 |
| S-8 | 5 |
| PREM14A | 1 |
| 8-A12B | 1 |
| SC 13D/A | 13 |
| SC 13D | 5 |
| 425 | 5 |
| SC 13G | 12 |
| 8-K/A | 3 |
| S-4 | 1 |
| DRSLTR | 1 |
| DRS | 1 |
| ARS | 2 |
| 10-K | 4 |
| 4/A | 9 |
| CERT | 1 |
| S-1/A | 2 |
| S-3MEF | 1 |
| SCHEDULE 13G | 1 |
| 144 | 87 |
| 424B5 | 5 |
| DEFA14A | 6 |
| SC 13G/A | 22 |
| 424B3 | 1 |
| DEFM14A | 1 |
| 424B4 | 1 |
| DRS/A | 1 |
| 4 | 243 |
| EFFECT | 4 |
| DEF 14A | 4 |
| 3 | 42 |
| S-4/A | 2 |
| SEC STAFF LETTER | 2 |
| S-1 | 1 |
| SCHEDULE 13G/A | 4 |
| S-3ASR | 1 |
| S-3 | 3 |
| D | 3 |
| PRE 14A | 1 |
| SCHEDULE 13D/A | 1 |
Financials
Total:65
Ipos
Total:21
Insider transactions
Total:294
Institutional filings
Total:21
Merger acquisition
Total:51